Pharma Pulse 7/1/24: AI Frenzy Propels Stocks to Monster First Half, Considerations for Integrating Artificial Intelligence & more

Considerations for Integrating Artificial Intelligence

In part 4 of this video interview, Diane Lacroix, vice president, clinical data management, eClinical Solutions discusses what industry stakeholders should be keeping top of mind when integrating AI into their workflows.

Healthcare Takes Backseat in Biden-Trump Debate. Biden's Age Not So Much

The presidential candidates didn't spend a lot of time talking about healthcare issues last night, but Democrats are concerned about Biden's performance, especially in the early going.

AI Frenzy Propels Stocks to Monster First Half

S&P 500 has climbed 15% despite reduced hopes for Federal Reserve interest-rate cuts.

Global mRNA Cancer Vaccines Clinical Trials & Future Market Outlook 2024 - ResearchAndMarkets.com

The "Global mRNA Cancer Vaccines Clinical Trials & Market Future Outlook 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.

Global mRNA Cancer Vaccines Clinical Trials & Future Market Outlook 2024 Report Highlights:

• mRNA Cancer Vaccines in Clinical Trials: > 60 Vaccines
• Highest Phase of Clinical Trials: Phase III (2 Vaccine)
• mRNA Cancer Vaccine Clinical Trials Insight by Company, Country, Indication & Phase
• First Commercial mRNA Vaccine Approval Expected by 2029
• US & China Dominating mRNA Cancer Vaccines Clinical Trials: > 45 Vaccines
• mRNA Vaccines for Skin Cancer Dominating Trials: > 10 Vaccines

@ICONplc on X

The future of clinical research focuses on sustainability and patient-centricity. Discover key considerations for greener supply chain management in this piece from @Clin_Trials : https://ow.ly/oYMj50Sq0Ms

Have news you want us to share in Pharma Pulse? Reach out to Social

Media Editor Miranda Schmalfuhs